Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action 2022-09-07 14:32
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds 2022-09-07 06:01
Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 2022-09-06 20:00
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study 2022-09-06 17:02
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives 2022-09-05 16:00
Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity 2022-09-05 08:00
Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer 2022-09-05 07:00
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 2022-09-02 09:41
Antengene Announces XPOVIO® Included for Reimbursement by the PBS in Australia for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma 2022-09-01 08:30
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum 2022-09-01 07:30
Broncus (02216.HK) announced interim results 2022-08-31 22:04
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator 2022-08-31 21:00
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey 2022-08-31 20:00
Quris Earns Frost & Sullivan 2022 Europe Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction 2022-08-31 20:00
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS 2022-08-31 15:29
Antengene Announces Interim 2022 Financial Results and Provides Corporate Update 2022-08-31 08:29
Viva Biotech Announced 2022 Interim Results 2022-08-29 23:55
Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation 2022-08-29 21:26
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences 2022-08-29 21:00
1 156 157 158 159 160 453